Michel Gardet

Global Business Head-Healthcare Nutrition at Nestlé Health Science SA

Michel Gardet

Michel Gardet

Global Business Head-Healthcare Nutrition at Nestlé Health Science SA

Biography

Mr. Michel Gardet is Global Business Head-HealthCare Nutrition at Nestlé Health Science S.A.Mr. Gardet also served on the board at Glycom A.

Overview
RelSci Relationships

37

Number of Boards

2

Relationships
RelSci Relationships are individuals Michel Gardet likely has professional access to. A relationship does not necessarily indicate a personal connection.

President, Chief Executive Officer & Director at Nestlé Health Science SA

Relationship likelihood: Strong

Chief Executive Officer at Nestle Health Science SA (Private Equity)

Relationship likelihood: Strong

Former Chief Executive Officer at Dako A/S

Relationship likelihood: Average

Professional at Technical University of Denmark

Relationship likelihood: Average

Head of Consumer Health at Bayer AG

Relationship likelihood: Average

Former Director at Glycom A/S

Relationship likelihood: Average

Former Head-Research & Development at Nestlé Nutrition

Relationship likelihood: Average

Professor at University of Hamburg

Relationship likelihood: Average

Portfolio Manager at Acesion Pharma ApS

Relationship likelihood: Average

Co-Founder at Glycom A/S

Relationship likelihood: Average

Paths to Michel Gardet
Potential Connections via
Relationship Science
You
Michel Gardet
Global Business Head-Healthcare Nutrition at Nestlé Health Science SA
Career History
Global Business Head-Healthcare Nutrition
Current

Nestlé Health Science SA develops nutritional therapies. Its health management services include aging, brain health, chronic medical conditions, critical care and surgery, food allergy, gastro intestinal, metabolic diseases, an obesity pediatrics. The company was founded in 2011 and is headquartered in Lutry, Switzerland.

Boards & Committees
Member, Board of Directors
Current

Phagenesis Ltd. develops a treatment for dysphagia. Its product Phagenyx consists of a base station and a treatment catheter which in combination enable the healthcare professional to deliver personalized dysphagia treatment for every patient. The company was founded by Conor Joseph Mulrooney and Shaheen Hamdy in 2007 and is headquartered in Manchester, the United Kingdom.

Director
Prior

Glycom A/S engages in the development, synthesis, and commercialization of human milk oligosaccharides. It develops chemical and enzymatic technologies for synthesis of human milk oligosaccharide powders. The company was founded by Gyuala Dekany, Mark Von Itzstein, Joachim Erich Thiem, Arnold Stutz, and Inge Lundt on March 22, 2005 and is headquartered in Horsholm, Denmark.

Other Affiliations

Michel Gardet is affiliated with Nestlé Health Science SA, Phagenesis Ltd., Glycom A/S

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Michel Gardet. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Michel Gardet's profile does not indicate a business or promotional relationship of any kind between RelSci and Michel Gardet.